MoleculeDx, Inc. is a molecular diagnostics company advancing research-driven approaches to cancer detection. Its scientific platform is grounded in more than a decade of peer-reviewed research on cancer-associated fusion genes and fusion transcripts. Through Fusion-detect™ Technology, MoleculeDx focuses on multi-marker molecular analysis and the study of circulating fusion-transcript signals, supporting evidence-based research in hepatocellular carcinoma and other areas of cancer science.